These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28475076)

  • 61. Naives, nonresponders, relapsers: who is there left to treat?
    Desai AP; Reau N
    Clin Liver Dis; 2011 Aug; 15(3):483-95. PubMed ID: 21867932
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Advisory panel: expand hepatitis therapy to HIV/AIDS patients.
    AIDS Policy Law; 2002 Jul; 17(12):2. PubMed ID: 12134793
    [No Abstract]   [Full Text] [Related]  

  • 63. One step closer to elimination of hepatitis C in Egypt.
    Esmat G; El-Sayed MH; Hassany M; Doss W; Waked I;
    Lancet Gastroenterol Hepatol; 2018 Oct; 3(10):665. PubMed ID: 30215356
    [No Abstract]   [Full Text] [Related]  

  • 64. Viral hepatitis in HIV infection.
    Koziel MJ; Peters MG
    N Engl J Med; 2007 Apr; 356(14):1445-54. PubMed ID: 17409326
    [No Abstract]   [Full Text] [Related]  

  • 65. World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013.
    Umar M; Khan AG; Abbas Z; Arora S; Asifabbas N; Elewaut A; Esmat G; Foster G; Fried M; Goh KL; Hamama TB; Imawari M; Isakov V; Krabshuis J; LaBrecque D; Lemair A; Malfertheiner P; Ryder S; Schiedermaier P; Stimac D; Tandon R; Villamil F; Zapata R; Ferenci P;
    J Clin Gastroenterol; 2014 Mar; 48(3):204-17. PubMed ID: 24504078
    [No Abstract]   [Full Text] [Related]  

  • 66. The smoldering epidemic. The number of new cases of hepatitis C is down, but millions are chronically infected and may not know it.
    Harv Health Lett; 2010 Sep; 35(11):1-3. PubMed ID: 20939121
    [No Abstract]   [Full Text] [Related]  

  • 67. Focus on hepatitis. Glimpses of hope on a distant horizon.
    Raymond D
    IAPAC Mon; 2004 Aug; 10(8):300-1. PubMed ID: 15719462
    [No Abstract]   [Full Text] [Related]  

  • 68. Hepatitis C: new treatment overview.
    Stoia J
    AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection: epidemiology, severity and recent therapeutic strategies].
    Cacoub P; Pol S
    Rev Med Interne; 2005 Apr; 26(4):267-70. PubMed ID: 15820560
    [No Abstract]   [Full Text] [Related]  

  • 70. Hepatitis drug gets approval for coinfection treatment.
    AIDS Patient Care STDS; 2005 May; 19(5):351. PubMed ID: 15916498
    [No Abstract]   [Full Text] [Related]  

  • 71. [Editorial commentary: Hepatitis C].
    Pár A
    Orv Hetil; 2015 May; 156(21):835. PubMed ID: 26038989
    [No Abstract]   [Full Text] [Related]  

  • 72. Expanding access to treatment for HIV/HCV coinfected patients.
    HRSA Careaction; 2006 Aug; ():1-12. PubMed ID: 16969925
    [No Abstract]   [Full Text] [Related]  

  • 73. Hepatitis C virus and human immunodeficiency virus co-infection in women.
    Orenstein R; Tsogas N
    J Am Osteopath Assoc; 2001 Dec; 101(12 Suppl Pt 2):S1-6. PubMed ID: 11794748
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A message to Japan.
    Tanikawa K
    Oncology; 2002; 62 Suppl 1():101-2. PubMed ID: 11868777
    [No Abstract]   [Full Text] [Related]  

  • 75. Chronic viral hepatitis: always be current!
    Hochman JA; Balistreri WF
    Pediatr Rev; 2003 Dec; 24(12):399-410. PubMed ID: 14645627
    [No Abstract]   [Full Text] [Related]  

  • 76. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.
    Davis GL; Alter MJ; El-Serag H; Poynard T; Jennings LW
    Gastroenterology; 2010 Feb; 138(2):513-21, 521.e1-6. PubMed ID: 19861128
    [TBL] [Abstract][Full Text] [Related]  

  • 77. FDA notifications. FDA draft guidance on Hepatitis C/HIV coinfection.
    AIDS Alert; 2010 Nov; 25(11):129-30. PubMed ID: 21128355
    [No Abstract]   [Full Text] [Related]  

  • 78. Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.
    Verna EC; Saxena V; Burton JR; O'Leary JG; Dodge JL; Stravitz RT; Levitsky J; Trotter JF; Everson GT; Brown RS; Terrault NA;
    Transplantation; 2015 Aug; 99(8):1644-51. PubMed ID: 25715116
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatitis C: treatment challenges.
    Copley L
    Prof Nurse; 2003 Nov; 19(3):133-4. PubMed ID: 14639900
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmaceuticals. Advocates protest the cost of a hepatitis C cure.
    Cohen J
    Science; 2013 Dec; 342(6164):1302-3. PubMed ID: 24337268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.